Second, high-mobility group box 1 (HMGB1) is released from dying, necrotic, damaged tumor cells into the immune milieu and exerts robust immunomodulatory effects by binding to Toll-like receptor (TLR)-4 and TLR-9 (85, 86). The gene discussed is HMGB1; the disease is neoplasm.